(S (NP (NP (JJ Quantitative) (NN extraction)) (PP (IN of) (NP (NP (ADJP (JJ high) (HYPH -) (JJ dimensional)) (JJ mineable) (NNS data)) (PP (IN from) (NP (JJ medical) (NNS images)))))) (VP (VBZ is) (NP (NP (DT a) (NN process)) (VP (VBN known) (PP (IN as) (NP (NNS radiomics)))))) (. .))
(S (NP (NNP Radiomics)) (VP (VBZ is) (VP (VBN foreseen) (PP (IN as) (NP (NP (NP (DT an) (JJ essential) (JJ prognostic) (NN tool)) (PP (IN for) (NP (NML (NN cancer) (NN risk)) (NN assessment)))) (CC and) (NP (NP (DT the) (NN quantification)) (PP (IN of) (NP (JJ intratumoural) (NN heterogeneity)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (NP (CD 1615) (JJ radiomic) (NNS features) (PRN (-LRB- -LRB-) (FRAG (NP (VBG quantifying) (NN tumour) (NN image) (NN intensity)) (, ,) (NP (NN shape) (, ,) (NN texture))) (-RRB- -RRB-))) (VP (VBN extracted) (PP (IN from) (NP (NP (JJ pre-treatment) (NML (NML (NN FDG) (HYPH -) (NN PET)) (CC and) (NML (NN CT))) (NNS images)) (PP (IN of) (NP (CD 300) (NNS patients))))) (PP (IN from) (NP (CD four) (JJ different) (NNS cohorts))))) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NP (DT the) (NN risk) (NN assessment)) (PP (IN of) (NP (NP (NP (JJ locoregional) (NNS recurrences)) (-LRB- -LRB-) (NP (NN LR)) (-RRB- -RRB-)) (CC and) (NP (NP (JJ distant) (NNS metastases)) (-LRB- -LRB-) (NP (NN DM)) (-RRB- -RRB-)))))) (PP (IN in) (NP (NML (NN head) (HYPH -) (CC and) (HYPH -) (NN neck)) (NN cancer))))) (. .))
(S (NP (NP (NN Prediction) (NNS models)) (VP (VBG combining) (NP (ADJP (JJ radiomic) (CC and) (JJ clinical)) (NNS variables)))) (VP (VBD were) (VP (VBN constructed) (PP (IN via) (NP (NP (JJ random) (NNS forests)) (CC and) (NP (NML (NN imbalance) (HYPH -) (NN adjustment)) (NNS strategies)))) (S (VP (VBG using) (NP (NP (CD two)) (PP (IN of) (NP (DT the) (CD four) (NNS cohorts)))))))) (. .))
(S (NP (NP (NP (JJ Independent) (NN validation)) (PP (IN of) (NP (DT the) (NN prediction)))) (CC and) (NP (NP (JJ prognostic) (NN performance)) (PP (IN of) (NP (DT the) (NNS models))))) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (PP (IN on) (NP (DT the) (JJ other) (CD two) (NNS cohorts) (PRN (-LRB- -LRB-) (NP (NN LR)) (: :) (S (S (NP (NN AUC)) (VP (SYM =) (NP (CD 0.69)))) (CC and) (S (NP (NN CI)) (VP (SYM =) (NP (CD 0.67))))) (: ;) (NP (NN DM)) (: :) (S (S (NP (NN AUC)) (VP (SYM =) (NP (CD 0.86)))) (CC and) (S (NP (NN CI)) (VP (SYM =) (NP (CD 0.88))))) (-RRB- -RRB-)))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (NNS results)) (VP (VBN obtained) (PP (IN via) (NP (NP (NNP Kaplan) (HYPH -) (NNP Meier)) (NP (NN analysis)))))) (VP (VBD demonstrated) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (NNS radiomics)))) (PP (IN for) (S (VP (VBG assessing) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (JJ specific) (NN tumour) (NNS outcomes)) (VP (VBG using) (NP (JJ multiple) (NN stratification) (NNS groups)))))))))) (. .))
(S (NP (DT This)) (VP (MD could) (VP (VB have) (NP (JJ important) (JJ clinical) (NN impact)) (, ,) (PP (ADVP (RB notably)) (IN by) (S (VP (VBG allowing) (PP (IN for) (NP (NP (DT a) (JJR better) (NN personalization)) (PP (IN of) (NP (NP (NML (NN chemo) (HYPH -) (NN radiation)) (NNS treatments)) (PP (IN for) (NP (NML (NN head) (HYPH -) (CC and) (HYPH -) (NN neck)) (NN cancer) (NNS patients))))))) (PP (IN from) (NP (JJ different) (NN risk) (NNS groups)))))))) (. .))
